Q

QTTB

QTTB

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
10%Bearish
Buy/Sell Ratio98% buys
BearishBullish
QTTB Live QuoteReal-time
$8.48
$0.19(-2.19%)1M
Day Range$8.21 – $8.66
Open$8.48
Previous Close$8.53
Volume312.2K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$253.75M
P/E Ratio (TTM)2.4
Forward P/ENaN
EPS (TTM)$3.59
Price to Book0.9
Dividend Yield0.65%
Beta (Volatility)-0.11
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $8.48 (30%)
Low: $1.98High: $23.57
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$39.67-73.6% upside

Insider Buys

2

$30.00M

Insider Sales

14

$537K

Total Volume

$30.54M

21 transactions

Net Activity

+$29.46M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
80CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Strong buying bias: purchases represent 98% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale Insiders

0 buys5 sells

$1171.88B total

X
2

Xu Diyong

Dir, 10%

1 buys0 sells

$15.00M total

O
3

Orbimed Advisors LLC

Dir, 10%

1 buys0 sells

$15.00M total

M
4

Morrison Jodie Pope

CEO

0 buys5 sells

$331K total

K
5

Kalowski Lee

CFO, Pres

0 buys5 sells

$134K total

Trading History
QTTB insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 6, 2026

1 months ago

Morrison Jodie Pope

CEO

CEO
Sell3.2K$8.32$27K

Oct 6, 2026

1 months ago

Violette Shelia M.

Chief Scientific Officer

C-Level
Sell917$8.32$8K

Oct 6, 2026

1 months ago

Kalowski Lee

CFO, Pres

CFO
Sell1.3K$8.32$11K

Aug 25, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell343.3K$-9845.00$0

Aug 25, 2026

2 months ago

Morrison Jodie Pope

CEO

CEO
Sell9.8K$16.56$163K

Aug 25, 2026

2 months ago

Kalowski Lee

CFO, Pres

CFO
Sell4.0K$16.56$66K

Aug 25, 2026

2 months ago

Violette Shelia M.

Chief Scientific Officer

C-Level
Sell2.8K$16.56$46K

May 28, 2026

5 months ago

Xu Diyong

Dir, 10%

Director
Buy1.88M$8.00$15.00M

May 28, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell625.0K$1875000.00$1171.88B

May 28, 2026

5 months ago

Orbimed Advisors LLC

Dir, 10%

Director
Buy1.88M$8.00$15.00M

Feb 25, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell35.9K$-3995.00$0

Feb 25, 2026

8 months ago

Kalowski Lee

CFO, Pres

CFO
Sell4.0K$4.51$18K

Feb 25, 2026

8 months ago

Morrison Jodie Pope

CEO

CEO
Sell9.9K$4.51$45K

Feb 25, 2026

8 months ago

Violette Shelia M.

Chief Scientific Officer

C-Level
Sell2.8K$4.51$13K

Dec 2, 2025

11 months ago

Kalowski Lee

CFO, Pres

CFO
Sell9.1K$3.46$31K

Dec 2, 2025

11 months ago

Morrison Jodie Pope

CEO

CEO
Sell22.5K$3.46$78K

Dec 2, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell99.0K$-22506.00$0

Aug 26, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell121.5K$-10494.00$0

Aug 26, 2025

15 months ago

Kalowski Lee

CFO, Pres

CFO
Sell4.2K$1.80$8K

Aug 26, 2025

15 months ago

Morrison Jodie Pope

CEO

CEO
Sell10.5K$1.80$19K

Aug 26, 2025

15 months ago

Violette Shelia M.

Chief Scientific Officer

C-Level
Sell3.0K$1.80$5K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
QTTB Buy Conviction98%
Industry Rank#0 of 569
Volume Contribution0.2%
Total Industry Activity$16.52B

QTTB has an insider buy conviction of 98%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for QTTB

Over the last 90 days, corporate insiders at QTTB (QTTB) engaged in a total of 21 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 14 were sales. The total volume of insider trading reached $30.54M.

The net insider activity for QTTB shows a net buying bias of $29.46M. This activity represents a 98% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 625.0K shares valued at $1171.88B on May 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for QTTB (QTTB)
6 updates

Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround

Yahoo Finance74d ago

QTTB - Q32 Bio Inc Stock Price and Quote

Finviz177d ago

(QTTB) Price Dynamics and Execution-Aware Positioning

Stock Traders Daily2d ago

$QTTB stock is down 15% today. Here's what we see in our data.

Quiver Quantitative51d ago

Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

PR Newswire130d ago

Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?

Yahoo Finance95d ago

FAQs About QTTB Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for QTTB.

Based on SEC Form 4 disclosures, the Insider Confidence Score for QTTB is currently 80/100, which reflects a strong accumulation bias. This calculation accounts for a total of 2 purchases and 14 sales by company executives over the last 90 days.

The CEO Conviction Index for QTTB is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.